Workflow
Binary Ionization Technology® (BIT™)
icon
Search documents
TOMI Environmental Solutions, Inc. Announces Filing of $50 Million Universal Shelf Registration Statement and Equity Line of Credit
Globenewswire· 2025-11-17 13:30
Core Viewpoint - TOMI Environmental Solutions, Inc. has filed a $50 million universal shelf registration statement with the SEC to enhance its financial flexibility for operational growth and strategic initiatives [1][2]. Financial Strategy - The registration statement will allow TOMI to offer and sell securities as needed, providing the company with the ability to efficiently access capital [2]. - TOMI has entered into a strategic advisory and placement arrangement with Bancroft Capital and established an equity line of credit (ELOC) facility with Hudson Global Ventures, allowing the sale of up to $20 million of common stock over a 24-month period [3]. Operational Performance - The CEO of TOMI highlighted strong sequential revenue growth and improved gross margins in Q3, indicating expanding customer adoption of the SteraMist® technology [4]. - The financing from the ELOC is intended to accelerate investments in innovation, manufacturing efficiency, and global distribution [4]. Company Overview - TOMI Environmental Solutions, Inc. specializes in disinfection and decontamination through its Binary Ionization Technology® (BIT™) platform, which utilizes a low percentage of Hydrogen Peroxide to create a germ-killing aerosol [5]. - The company's products are designed for a wide range of commercial structures, including hospitals, cruise ships, schools, and military facilities [6].
TOMI Environmental Solutions, Inc. Reports Q3 2025 Financial Results and Outlines Growth Initiatives
Globenewswire· 2025-11-14 21:05
Core Insights - TOMI Environmental Solutions, Inc. reported a significant sequential revenue increase of 95% in Q3 2025, driven by higher equipment purchases and strong recurring sales of its BIT™ Solution [5][10] - The company is strategically positioned for long-term growth, with ongoing investments in R&D and expanding international market penetration [10][11] Financial Performance - Revenues for Q3 2025 were $2.0 million, a 95% increase from Q2 2025, but a decrease from $2.54 million in Q3 2024 [5][25] - Gross profit margin remained stable at 61% for Q3 2025, indicating operational efficiency [5][25] - Operating loss for Q3 2025 was $(321,000), compared to an operating income of $149,000 in Q3 2024 [5][25] - Net loss for Q3 2025 was $(450,000) or $(0.02) per share, compared to a net income of $59,000 or $0.00 per share in Q3 2024 [5][25] Business Highlights - The company achieved a 21% year-over-year increase in SteraMist solution sales for the nine months ended September 30, 2025 [5] - International revenue accounted for nearly 36% of Q3 revenue, up from 20% in Q2 2025, reflecting successful global market penetration [5] - The sales order backlog grew to $0.9 million at quarter-end and expanded to $1.3 million by October 31, with approximately $3 million in pending contracts expected to close before year-end [5] Strategic Initiatives - The company is focusing on expanding its product applications across various sectors, including life sciences, healthcare, food safety, and commercial markets [5][10] - A new equity line of credit allows the company to sell up to $20 million in common stock over a 24-month period, enhancing financial flexibility [8][9] - The FDA's expanded approval for hydrogen peroxide use is expected to broaden the application of SteraMist iHP technology, targeting food, agriculture, and environmental biosecurity markets [10][12] Liquidity and Capital Access - As of September 30, 2025, the company had working capital of $2.5 million, with cash used in operations improving by approximately $876,000 compared to the same period in 2024 [7] - The company completed a $535,000 convertible note financing to support growth initiatives [7] Executive Commentary - The CEO highlighted the strong revenue growth and new customer partnerships as evidence of the effectiveness of the company's strategy and execution [10] - The company is optimistic about maintaining momentum into Q4 2025 and throughout 2026, supported by a growing customer base and expanding sales [11][12]
TOMI Environmental Solutions to Showcase Decontamination Innovations at AALAS 76th National Meeting
Globenewswire· 2025-11-10 14:00
Core Insights - TOMI Environmental Solutions, Inc. is actively participating in the AALAS 76th National Meeting to enhance its presence in the animal research sector [1][2] - The event serves as a platform for TOMI to strengthen strategic partnerships and promote its SteraMist Integrated System (SIS) [2][3] - The company aims to leverage high-impact networking opportunities to drive the adoption of its innovative ionized Hydrogen Peroxide (iHP) technology [3][4] Company Overview - TOMI specializes in disinfection and decontamination solutions, utilizing its Binary Ionization Technology® (BIT™) platform, which is based on low percentage hydrogen peroxide [5] - The company’s products are designed for a wide range of applications, including hospitals, biosafety labs, and food processing facilities [5] Event Participation - AALAS is a significant event for TOMI, attracting thousands of professionals from research institutions, which facilitates lead generation and collaboration [3] - The executive team, including key leaders from various departments, will represent TOMI at the event, highlighting the company's commitment to innovation and customer-centric growth [4][5]
TOMI Environmental Solutions Expands into Aquaculture with New Partner, Algafeed
Newsfilter· 2025-03-21 12:30
Core Insights - TOMI Environmental Solutions, Inc. has successfully implemented its SteraMist technology at Algafeed, addressing contamination issues in microalgae production for aquaculture [1][2] - Algafeed faced significant Protozoan ciliate contamination, which was effectively reduced through the use of SteraMist, allowing for improved production volumes [2][4] - The partnership between TOMI and Algafeed highlights the versatility of SteraMist technology in various industries, particularly in aquaculture [4] Company Overview - TOMI Environmental Solutions, Inc. specializes in disinfection and decontamination solutions, utilizing its Binary Ionization Technology® (BIT™) platform, which employs a low percentage of hydrogen peroxide as the active ingredient [5] - The company’s products are designed for a wide range of applications, including hospitals, pharmaceutical facilities, schools, and food processing facilities [5] Industry Context - Algae serves as a primary food source in aquaculture, and Algafeed's innovative technology allows for high-density microalgae cultivation, providing a competitive edge in the industry [3] - The successful application of SteraMist technology in the aquaculture sector demonstrates the growing importance of effective disinfection solutions in maintaining production efficiency [2][4]